286 related articles for article (PubMed ID: 31062563)
1. Use of botulinum toxin A in children with cerebral palsy.
Ross Raftemo AE; Mahendran A; Hollung SJ; Jahnsen RB; Lydersen S; Vik T; Andersen GL
Tidsskr Nor Laegeforen; 2019 May; 139(8):. PubMed ID: 31062563
[TBL] [Abstract][Full Text] [Related]
2. Intrathecal Baclofen Infusion-Botulinum Toxin Combined Treatment Efficacy in the Management of Spasticity due to Cerebral Palsy.
Marvulli R; Lagioia G; Ianieri G; Dell'Olio L; Zonno A; Riccardi M; Sinisi RB; Rizzo LB; Farì G; Megna M; Ranieri M
CNS Neurol Disord Drug Targets; 2024; 23(7):917-926. PubMed ID: 38213169
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of spasticity in children with cerebral palsy with botulinum toxin A].
Madsen ES; Sonne-Holm S; Wong C; Curtis D; Bencke J
Ugeskr Laeger; 2015 Jan; 177(3):V07140409. PubMed ID: 25613095
[TBL] [Abstract][Full Text] [Related]
4. Treatment with Botulinum toxin A in a total population of children with cerebral palsy - a retrospective cohort registry study.
Franzén M; Hägglund G; Alriksson-Schmidt A
BMC Musculoskelet Disord; 2017 Dec; 18(1):520. PubMed ID: 29228927
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of incobotulinum toxin A [Xeomin(®)] in gastrocnemious muscles injections in children with cerebral palsy: Randomized double-blind clinical trial.
Carraro E; Trevisi E; Martinuzzi A
Eur J Paediatr Neurol; 2016 Jul; 20(4):532-7. PubMed ID: 27177451
[TBL] [Abstract][Full Text] [Related]
6. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
Meholjic A; Madjar D
Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
[TBL] [Abstract][Full Text] [Related]
7. Treatment of spasticity in children and adolescents with cerebral palsy in Northern Europe: a CP-North registry study.
Hägglund G; Hollung SJ; Ahonen M; Andersen GL; Eggertsdóttir G; Gaston MS; Jahnsen R; Jeglinsky-Kankainen I; Nordbye-Nielsen K; Tresoldi I; Alriksson-Schmidt AI
BMC Neurol; 2021 Jul; 21(1):276. PubMed ID: 34253183
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of botulinum toxin type A with oral anti-spasticity medications in the management of focal spasticity.
Dai A
J Rehabil Med; 2007 Mar; 39(2):189; author reply 189. PubMed ID: 17351705
[No Abstract] [Full Text] [Related]
9. Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin.
Koman LA; Paterson Smith B; Balkrishnan R
Paediatr Drugs; 2003; 5(1):11-23. PubMed ID: 12513103
[TBL] [Abstract][Full Text] [Related]
10. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic evaluation of changes in the muscle architecture of the gastrocnemius with botulinum toxin treatment for lower extremity spasticity in children with cerebral palsy.
Kawano A; Yanagizono T; Kadouchi I; Umezaki T; Chosa E
J Orthop Sci; 2018 Mar; 23(2):389-393. PubMed ID: 29146092
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic interventions for reducing spasticity in cerebral palsy.
Patel DR; Soyode O
Indian J Pediatr; 2005 Oct; 72(10):869-72. PubMed ID: 16272661
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Efficacy and Side Effects of Oral Baclofen Versus Tizanidine Therapy with Adjuvant Botulinum Toxin Type A in Children With Cerebral Palsy and Spastic Equinus Foot Deformity.
Dai AI; Aksoy SN; Demiryürek AT
J Child Neurol; 2016 Feb; 31(2):184-9. PubMed ID: 25999301
[TBL] [Abstract][Full Text] [Related]
14. Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity.
Yang TF; Fu CP; Kao NT; Chan RC; Chen SJ
Am J Phys Med Rehabil; 2003 Apr; 82(4):284-9. PubMed ID: 12649654
[TBL] [Abstract][Full Text] [Related]
15. New approaches to managing spasticity in children with cerebral palsy.
Im D; McDonald CM
West J Med; 1997 Apr; 166(4):271. PubMed ID: 9168686
[No Abstract] [Full Text] [Related]
16. [Botulinum toxin for postoperative care after limb surgery in cerebral palsy children].
Dohin B; Garin C; Vanhems P; Kohler R
Rev Chir Orthop Reparatrice Appar Mot; 2007 Nov; 93(7):674-81. PubMed ID: 18065878
[TBL] [Abstract][Full Text] [Related]
17. Botulinum Toxin: Techniques Within Pediatric Physiatry.
Paulson A; Zigler CK; Houtrow A; Pruitt D
PM R; 2019 Jan; 11(1):38-44. PubMed ID: 29964211
[TBL] [Abstract][Full Text] [Related]
18. Treatment with botulinum toxin in children with cerebral palsy: a qualitative study of parents' experiences.
Lorin K; Forsberg A
Child Care Health Dev; 2016 Jul; 42(4):494-503. PubMed ID: 27198886
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
Dai AI; Wasay M; Awan S
J Child Neurol; 2008 Dec; 23(12):1464-6. PubMed ID: 19073853
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]